Current evidence indicates that 5‐HT4R is upregulated in various tumor types, including cholangiocarcinoma, colon cancer, and breast cancer, where 5‐HT promotes tumor cell growth and proliferation through 5‐HT4R‐mediated signaling [412]. Here, HTR4 is linked to breast carcinoma.